Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial

Show other versions (2)

Background: Diabetes has a high burden of illness both in life years lost and in disability through related co-morbidities. Accurate assessment of the non-mortality burden requires appropriate health-related quality of life and summary utility measures of which there are several contenders. The stud...

Full description

Bibliographic Details
Main Authors:	Glasziou, P, Alexander, J, Beller, E, Clarke, P, Chalmers, J, MacMahon, S, Cooper, M, Ferrannini, E, Grobbee, D, Hamet, P, Harrap, S, Heller, S, Lisheng, L, Mancia, G, Marre, M, Mogensen, C, Neal, B, Yu Pan, C, Patel, A, Poulter, N, Rodgers, A, William, B, Woodward, M, Collins, R
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
by: Patel, A, et al.
Published: (2007)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
by: Zoungas, S, et al.
Published: (2009)

Lowering blood pressure reduces renal events in type 2 diabetes.
by: de Galan, B, et al.
Published: (2009)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
by: Patel, A, et al.
Published: (2008)

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
by: Kengne, A, et al.
Published: (2009)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
by: Ohkuma, T, et al.
Published: (2018)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
by: Hata, J, et al.
Published: (2013)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
by: Hata, J, et al.
Published: (2013)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
by: Zoungas, S, et al.
Published: (2012)

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
by: Atkins, A, et al.
Published: (2017)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
by: Perkovic, V, et al.
Published: (2013)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
by: Clarke, P, et al.
Published: (2010)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
by: Hua, X, et al.
Published: (2020)

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
by: Glasziou, P, et al.
Published: (2010)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
by: Rådholm, K, et al.
Published: (2018)

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial.
by: Glasziou, P, et al.
Published: (2007)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
by: Kamel Mohammedi, et al.
Published: (2021-01-01)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
by: Rahman, F, et al.
Published: (2019)

Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetes.
by: Salomon, J, et al.
Published: (2011)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
by: Mohammedi, K, et al.
Published: (2017)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
by: Mohammedi, K, et al.
Published: (2016)

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial
by: Glasziou, P, et al.
Published: (2007)

Which methods for bedside Bayes?
by: Glasziou, P
Published: (2001)

Which methods for bedside Bayes?
by: Glasziou, P
Published: (2001)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
by: Blomster, J, et al.
Published: (2017)

Focus on sharing individual patient data distracts from other ways of improving trial transparency.
by: Hoffmann, T, et al.
Published: (2017)

Severe Hypoglycemia and Risks of Vascular Events and Death
by: Zoungas, S, et al.
Published: (2010)

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial
by: Glasziou Paul, et al.
Published: (2007-04-01)

Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial.
by: Arima, H, et al.
Published: (2012)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
by: Ohkuma, T, et al.
Published: (2019)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
by: van Steen, S, et al.
Published: (2018)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
by: Ohkuma, T, et al.
Published: (2017)

APOE genotype, ethnicity, and the risk of cerebral hemorrhage
by: Tzourio, C, et al.
Published: (2008)

Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
by: Selvin, E, et al.
Published: (2019)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
by: Kamel Mohammedi, et al.
Published: (2017-07-01)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
by: Philip M Clarke, et al.
Published: (2010-02-01)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
by: Jun, M, et al.
Published: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
by: Jun, M, et al.
Published: (2017)